Professional Documents
Culture Documents
gov/Food/FoodScienceResearch/LaboratoryMethods/ucm2893
78.htm
Bacteriological Analytical Manual
Chapter 29
Cronobacter
BAM Table of Contents
March 2012: New Chapter (This chapter has replaced the method for Isolation and
Enumeration of Enterobacter sakazakii from Dehydrated Powdered Infant Formula
(available as archived content)).
April 2012: Sections D.1.a, D.1.b, D.2.3; Correction: The fluorescence is recorded at
the end of each annealing step, not at the end of each extension step.
Introduction
Cronobacter is a Gram-negative rod within the family Enterobacteriaceae (7). The organism
was called "yellow-pigmented Enterobacter cloacae" until it was renamed Enterobacter
sakazakii (6) in 1980. Urmenyi and Franklin reported the first two known cases of meningitis
caused by E. sakazakii in 1961 (11). Subsequently, cases of meningitis, septicemia, and
necrotizing enterocolitis due to E. sakazakii have been reported worldwide (9). Although
most documented cases involve infants, reports describe infections in adults as well. Overall,
case-fatality rates vary considerably with some as high as 80 percent (8). While a reservoir
for E. sakazakii is unknown, a growing number of reports suggest powdered infant formulas
as a vehicle for infection (12).
Recently obtained evidence using amplified fragment length polymorphism, phenotypic
arrays, automated ribotyping, 16S rRNA gene sequencing and DNA-DNA hybridization has
resulted in a nomenclature change. E. sakazakii was reclassified into a new genus,
Cronobacter, comprising five species including Cronobacter sakazakii gen. nov.,
Cronobacter malonaticus sp. nov., Cronobacter turicensis sp. nov., Cronobacter muytjensii
sp. nov., and Cronobacter dublinensis sp. nov. These species have all been previously
involved in clinical cases. One additional new species was also proposed, Cronobacter
genomospecies I (Table 1) (7).
Table 1. Biochemical tests for the differentiation of species and subspecies of the genus
Cronobacter (7).
Table 1. Biochemical tests for the differentiation of species and subspecies of the genus
Cronobacter (7).
C. saka C. malon C. turic C. genomos C. muytj C. dublin C. dublin C. dublin
zakii
aticus
ensis
pecies I
ensii
ensis
ensis
ensis
subsp. subsp. subsp.
dublinen lactaridi lausanne
sis
nsis
Indole
production
+
+
V
+
V
+
+
+
V
V
Dulcitol
Lactulose +
+
Malonated
+
Maltitol +
+
Palatinose +
+
Putrescine +
V
Melezitose
Turanose +
+
myoV
V
+
+
+
Inositol
cis+
+
+
+
V
Aconitate
trans
+
+
V
Aconitate
1-0Methyl aD+
+
+
+
glucopyra
noside
4Aminobut +
+
+
V
+
yrate
+: 90% Positive; V: 20-80% positive; : 10% positive
+
+
+
+
+
+
+
+
+
+
+
V
Method
The method described here contains both a real-time PCR method for rapid screening and a
cultural method for the detection/isolation of Cronobacter spp. (3). Chromogenic agars are
used to isolate the culture for confirmation. A pre-enrichment step is used to grow the
bacteria to an amount ( 103 CFU/ mL) detectable by PCR and chromogenic agars. The
cultural portion of this method is a complete detection/isolation method, so it can be used as a
stand alone method if PCR technology is unavailable. The PCR portion of the method is a
screening method, whose positive results should always be confirmed with the cultural
method. The PCR method may be used to confirm pure cultures as Cronobacter spp. This
method was validated in pre-collaborative and collaborative studies (1,2).
The inclusivity of this method was determined by analyzing 51 different Cronobacter strains
representing the six Cronobacter species that were isolated from foods, clinical samples,
environmental surfaces, and nationally/internationally recognized culture depositories. The
origin and source of each strain are listed in the Inclusivity Table (A). Each strain was
enriched in brain heart infusion (BHI) broth and diluted in buffered peptone water (BPW) to
approximately 10 times the limit of detection. The diluted cultures were then tested according
to this method.
The exclusivity of this method was determined by testing 42 non-Cronobacter strains. The
source and origin of each strain are listed in the Exclusivity Table (B). Each strain was
enriched in BHI broth. These incubated cultures were tested according to this method.
Equipment and materials
1. Balance with capacity of 2 kg and sensitivity of 0.1 g
2. Incubator, 36 1 C
3. Sterile Erlenmeyer flasks with polyethylene screw caps equipped with teflon liners, 2
liter
4. Micropipette and tips to dispense 1 L , 100 L, 150 L, and 200 L volumes
5. Pipets, 1, 5, and 10 mL, graduated in 0.1 mL units
6. Sterile inoculating loops, 3 mm loop size
7. Glass spreading rods (e.g., hockey stick) 3-4 mm diameter with 45-55 mm spreading
area
8. Sterile utensils for sample handling (see BAM Chapter 1)
9. Centrifuge with a swinging bucket rotor, capable of 3,000 g
10. Microcentrifuge, capable of 10,000 g
11. Centrifuge tubes, polypropylene, 50 mL tubes with conical bottoms; 1.5 mL
microcentrifuge tubes
12. Vortex mixer
13. Water bath, capable of 100 C
14. Thermal cyclers: ABI Prism 7500 Fast Sequence Detection System (Life
Technologies, Inc. Carlsbad, CA 92008), SmartCycler Real-Time PCR system
(Cepheid, Sunnyvale, CA 94089)
15. Sample tubes with centrifuge adapters for SmartCycler II (minimum reaction volume
of 25 L)
16. 96-well microwell plate
Name
Cronobacter
CronoF
forward
GGGATATTGTCCCCTGAAACAG
Cronobacter
CronoR
reverse
CGAGAATAAGCCGCGCATT
Cronobacter
CronoP
probe
6FAMAGAGTAGTAGTTGTAGAGGCCGTGCTTCCGAAAGTAMRA
Internal
control
forward
InCF
CTAACCTTCGTGATGAGCAATCG
Internal
control
reverse
InCR
GATCAGCTACGTGAGGTCCTAC
Internal
InCP
control probe
Cy5-AGCTAGTCGATGCACTCCAGTCCTCCT-Iowa Black
RQ-Sp.
12. Internal Control DNA (3): Internal control (InC) DNA is constructed by generating a
198 bp sequence that is synthesized and inserted into a pZErO-2 vector and
transformed into Escherichia coli pDMD801 partial sequence representation
containing the internal control is shown below (GenBank accession no. FJ357008,
Figure 1). The internal control DNA (IAC in Figure 1) sequence is in grey, T7
promoter is represented in a box, and M13, internal control forward and reverse
primers and probe targets are represented by arrows. The plasmid is extracted by
Qiagen Plasmid Mini Kit (Cat. No. 12125, Qiagen, Valencia, CA 91355) from the
transformed Escherichia coli cells following manufacturer's instructions and
quantified by NanoDrop ND1000. The internal control DNA can also be
commercially synthesized and diluted to a stock solution which will provide a reliable
Ct of no less than 24 when Cronobacter DNA are present and no more than 34 when
Cronobacter are not present.
Figure 1. Illustration of the internal control DNA
Volume/reaction
12.5 L
Final Concentration
50 mM KCl, 20 mM Tris-HCl, 0.2
mM each dNTP,
0.625 U iTaq DNA polymerase and 3
mM MgCl2
Component
Volume/reaction
Final Concentration
CronoF
900 nM
CronoR
900 nM
CronoP
250 nM
Taq Polymerase
0.1 L (5 U/ L)
0.5 U
DNA extract or
control
2 L
Volume/reaction
Final Concentration
IQ Supermix
12.5 L
CronoF
900 nM
CronoR
900 nM
CronoP
250 nM
InCF
1000 nM
InCR
1000 nM
InCP
250 nM
InC DNA
Component
Volume/reaction
Final Concentration
Taq Polymerase
0.5 L (5 U/ L)
2.5 U
MgCl2
3 mM
DNA extract or
control
2 L
b.
Volume/reaction
Final Concentration
IQ Supermix
12.5 L
CronoF
400 nM
CronoR
400 nM
CronoP
Taq Polymerase
0.1 L (5 U/ L)
DNA extract or
control
2 L
0.5 U
Table 6. PCR reaction components for ABI 7500 Fast with InC
Component
Volume/reaction
Final Concentration
IQ Supermix
12.5 L
CronoF
400 nM
CronoR
400 nM
CronoP
300 nM
InCF
150 nM
InCR
150 nM
InCP
150 nM
InC DNA
0.005 pg
Taq Polymerase
0.5 L (5 U/L)
2.5 U
MgCl2
3 mM
DNA extract or
control
2 L
To analyze the data, set auto baseline and set the threshold value to 50,000
units for both FAM and Cy5. Sample screen shots of the graph and table view
is shown in Figure 3. Follow the data interpretation criteria for the
SmartCycler to interpret the data.
Figure 3. Sample screenshots of the 7500 Fast result. The amplification curves
of Cronobacter (assigned as target 1) and InC (assigned as target 2) are shown
in the graph and the Ct values and dye sets are shown in the result table.
Isolation of Cronobacter
For CRO samples, spread 100 L aliquots of suspended cells (obtained in C8) evenly onto
each of the two DFI chromogenic agar (4) and two R&F Cronobacter chromogenic plating
agar (9) with sterile spreading rods. In addition, streak a loopful of aliquots of suspended
cells onto the surface of two DFI and two R&F agar with sterile inoculation loops. Incubate
the agar plates at 36 1 C for 18 to 24 h. Observe plates for colonial morphology typical of
Cronobacter (Figure 4). If the cultures overgrow on the plates, streak a 3 mm loopful (10 L)
of lawn materials to at least three quadrants of a new plate for isolation of single colonies.
Figure 4b. Cronobacter colonies on R&F agar. The plate on the right shows an infant
formula sample with Cronobacter and background flora. The background flora changes the
background color of the agar from red to yellow in most areas. Cronobacter colonies are
green with yellow background and black with red background.
A Identification of Cronobacter
Presumptive Cronobacter colonies on DFI agar appear either dark green, weak green,
or brownish green. Some colonies only have a green center with a white/yellow
border. Presumptive Cronobacter colonies on R&F agar appear blue to black, or blue
to grey with the red background. The red background can appear purplish red with
different strain or under different light conditions. Cronobacter does not change the
color of R&F agar, but in the presence of background microflora which change the
color of R&F agar from red to yellow, Cronobacter colonies appear blue to green
(Figure 4b).
1. Biochemical confirmation
Cultures for biochemical identification must be no older than 24 h. With a
sterile inoculating loop, pick one presumptive Cronobacter colony from each
DFI agar and R&F agar plate and confirm using Rapid ID 32 E or VITEK 2.0
biochemical identification system according to the manufacturer's instructions.
For positive identification with Rapid ID 32 E, the oxidase test must be
included.
2. PCR confirmation
Prepare DNA of presumptive positive colonies on DFI and R&F agar plates.
Add a small amount of colony material to 150 L of PCR grade dH2O
contained in a 1.5 mL plastic centrifuge tube and boil for 5 min in a boiling
water bath. Chill the tubes in ice and centrifuge at 10,000 g for 2 min. Use 1
L of this lysed material as DNA template for the real-time PCR assay with
any of the mentioned PCR protocols above.
B Optional: enumeration of Cronobacter
Use the three-tube Most Probably Number (MPN) procedure (BAM Manual,
Appendix 2; Most Probable Number Determination from Serial Dilutions; ).
Aseptically weigh out in triplicate, 100 g, 10 g and 1 g of the powdered infant formula
and add to 2 liter, 250 mL and 125 mL size Erlenmeyer flasks, respectively and
proceed with sample preparation, culture isolation and identification. Calculate MPN
of Cronobacter cells/g of sample based on the number of "tubes" at each dilution in
which the presence of Cronobacter was confirmed.
C Flowchart of the complete procedure
References
1.
Chen, Y., K.E. Noe, S. Thompson, C.A. Elems, E.A. Brown, K.A. Lampel, and T.S.
Hammack. 2011. Evaluation of a revised FDA method for the detection of
Cronobacter in powdered infant formula: Collaborative study. J. Food Prot. In Press.
2.
Chen, Y., T.S. Hammack, K.Y. Song, and K.A. Lampel. 2009. Evaluation of a revised
U.S. Food and Drug Administration method for the detection and isolation of
Chen, Y., K.Y. Song, E.W. Brown and K.A. Lampel. 2010. Development of an
improved protocol for the isolation and detection of Enterobacter sakazakii
(Cronobacter) from powdered infant formula. J. Food Prot. 73:1016-1022.
4.
5.
Druggan, P. and C.Iversen. 2009. Culture media for the isolation of Cronobacter spp.
Int. J. Food Microbiol. 136:169-178.
6.
Farmer J.J., III, M.A. Asbury, F.W. Hickman. The Enterobacteriaceae Study Group
and D.J. Brenner. 1980. Enterobacter sakazakii: A new species of
"Enterobacteriaceae" isolated from clinical specimens. Intl. J. Syst. Evol. Microbiol.
30:569-584.
7.
8.
Lai, K.K. 2001. Enterobacter sakazakii infections among neonates, infants, children,
and adults. Case reports and a review of the literature. Medicine (Baltimore). 80:113122.
9.
10. Restaino, L., E.W. Frampton, W.C. Lionberg, and R.J. Becker. 2006. A chromogenic
plating medium for the isolation and identification of Enterobacter sakazakii from
foods, food ingredients, and environmental sources. J. Food Prot. 69:315-322.
11. Urmenyi, A.M. and A.W. Franklin. 1961. Neonatal death from pigmented coliform
infection. Lancet. 1:313-315.
12. World Health Organization. Enterobacter sakazakii and other microorganisms in
powdered infant formula: meeting report. 2004.
Appendix
Table A. Inclusivity Testing Results for Cronobacter
Original Lab Original ID
Organism
UCDc/UZHd/ E265
NRCe
C.
milk
malonaticus powder
ILSIf
F6-036
ILSI
F6-038
ILSI
F6-040
UCD/UZH/N E464
RC
C.
dublinensis
ATCCg;
NCTCh
ATCC
C. sakazakii human
29544;
(throat)
NCTC 11467
FDAi
607
UCD/UZH/N E515
RC
water
ATCC
ATCC
ATCC 51329 C.
muytjensii
UCD/UZH/N E632
RC
C. sakazakii food
USA
HCSC
HPB 2848
C. sakazakii clinical
HCSC
HPB 2873
C. sakazakii clinical
Organism
HCSC
HPB 2874
C. sakazakii clinical
ve
cter
ve
France
Russia
Russia
CDCk
CDC 596070
C.
dublinensis
USA
CDC
CDC 352375
C.
human USA
malonaticus (bone
marrow)
NCTC
NCTC
ATCC
ATCC
BAA893
ATCC
ATCC
BAA894
CDC
human
(blood)
UK
USA
Organism
CDC
CDC 105877
C.
human USA
malonaticus (breast
abscess)
CDC
CDC
CDC 312877
CDC
CDC 936975
UZH
z3032
HCSC
ILSI
SK81
F6-023
C. sakazakii human
ILSI; RADl
F6-029
C. sakazakii neonate
ILSI
USA
ILSI
USA
CDC;
ILSI
CDC 289-81; C.
clinical
F6-049
malonaticus
USA
CDC;
ILSI
CDC 171677;
F6-052
USA
ILSI;
RAD
F6-032;
C. sakazakii milk
H. Muytjens
powder
7
UCD
CFS112
C. sakazakii milk
powder
Ireland
UCD
CFS349N
C. sakazakii milk
powder
New
Positi Positi Cronoba Positi
Zealand ve
ve
cter
ve
UCD
CFS352N
C. sakazakii milk
powder
New
Positi Positi Cronoba Positi
Zealand ve
ve
cter
ve
UCD
ES187
C.
dublinensis
Ireland
CDC
CDC 936375
C. sakazakii stool
USA
C. sakazakii human
(blood)
milk
powder
Organism
CDC
CDC 496371
C. sakazakii stool
USA
CDC
CDC 189573
C.
human USA
malonaticus (faeces)
RFm
ES626
Organism
Source
DFIa
R&Fb
ATCCc
13047
Enterobacter
cloacae
spinal
fluid
ATCC
13048
Enterobacter
aerogenes
sputum
ATCC
13182
Klebsiella oxytoca
ATCC
13880
ATCC
14485
Organism
Source
soil
DFIa
R&Fb
ATCC
14807
Bacillus subtilis
ATCC
15469
ATCC
23055
ATCC
23216
Leclercia
adecarboxylata
ATCC
25830
Morganella
morganii
ATCC
25922
Escherichia coli
clinical
isolate
ATCC
27028
Citrobacter koseri
blood
culture
ATCC
27982
Pantoea
agglomerans
ATCC
29013
Klebsiella
pneumoniae
blood
ATCC
29944
ATCC
27853
Pseudomonas
fluorescens
ATCC
13472
Bacillus cereus
unknown No
No
nonNegati
growth growth Cronoba ve
cter
ATCC
33105
Serratia ficaria
ATCC
33420
Proteus vulgaris
clinical
isolate
Organism
Source
DFIa
R&Fb
ATCC
33650
Escherichia
hermanii
human
toe
ATCC
15246
ATCC
33832
ATCC
29212
Enterococcus
faecalis
ATCC
10054
ATCC
51713
ATCC
25741
Pediococus
acidilactici
ATCC
8090
ATCC
9789
Bacillus
licheniformis
milk
No
No
nonNegati
growth growth Cronoba ve
cter
UZHd/UCDe/ E440
NRCf
Enterobacter
helveticus
sp. nov
milk
powder
UZH/UCD/N E441
RC
Enterobacter novel
species
milk
powder
UZH/UCD/N E644
RC
Enterobacter
cloacae
unknown No
No
nonNegati
growth growth Cronoba ve
cter
unknown No
No
nonNegati
growth growth Cronoba ve
cter
milk
powder
ILSIg
F6-026
Enterobacter
asburiae
Organism
Source
DFIa
R&Fb
ILSI
F6-033
Enterobacter
hormaechei
milk
powder
Enterobacter
turicensis,
sp. nov
fruit
powder
LMG; UZH
LMG
23732
Enterobacter
helveticus,
sp. nov
fruit
powder
UZH
fruit
powder
FDAi
FDA
Yp 1313
Yersinia
unknown Negativ Negativ nonNegati
pseudotuberculosis
e
e
Cronoba ve
cter
FDA
Ye 37
Yersinia
enterocolitica
FDA
2457T
Shigella flexneri
clinical
Shigella sonnei
clinical
FDA
False-positive
a
4 / 42
4 / 42
0 / 42
1 / 42